Pemafibrate-based solutions for sustainable agriculture, biofuel production, wastewater treatment, environmental monitoring, and bioremediation

Publication ID: 24-11857540_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Pemafibrate-based solutions for sustainable agriculture, biofuel production, wastewater treatment, environmental monitoring, and bioremediation,” Published Technical Disclosure No. 24-11857540_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857540_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,540.

Summary of the Inventive Concept

This inventive concept leverages pemafibrate's PPARα activity to develop innovative solutions for various industries, including agriculture, biofuel production, wastewater treatment, environmental monitoring, and bioremediation, by applying the core technology in new and unexpected ways.

Background and Problem Solved

The original patent focuses on pemafibrate dosing regimens for treating dyslipidemia. However, the limitations of the original patent lie in its narrow application scope. This inventive concept addresses the need for more versatile and sustainable solutions in various industries, where pemafibrate's PPARα activity can be harnessed to drive innovation.

Detailed Description of the Inventive Concept

The newly generated claims describe pemafibrate-based systems, methods, and compositions for optimizing crop yields, enhancing biofuel production, treating wastewater, monitoring environmental pollutants, and bioremediating contaminated soil. These applications utilize pemafibrate's ability to modulate PPARα activity, combined with OATP1B inhibitors, to achieve unprecedented results. For instance, in agriculture, pemafibrate-based plant growth promoters can increase crop yields while reducing soil toxicity. In biofuel production, pemafibrate can stimulate lipid biosynthesis in microorganisms, while OATP1B inhibitors regulate nutrient uptake. Similarly, pemafibrate can be used to reduce organic pollutants in wastewater treatment and detect environmental pollutants in monitoring systems. Finally, pemafibrate can stimulate microbial degradation in bioremediation processes.

Novelty and Inventive Step

The novelty of this inventive concept lies in the unexpected application of pemafibrate's PPARα activity to entirely new industries and use cases, which were not contemplated in the original patent. The inventive step is the recognition of pemafibrate's potential to drive innovation in these fields, combined with the strategic integration of OATP1B inhibitors to achieve synergistic effects.

Alternative Embodiments and Variations

Alternative embodiments may include using pemafibrate in combination with other PPARα agonists or antagonists, or exploring different formulations and delivery methods for the pemafibrate-based systems and compositions. Variations may also involve adapting the inventive concept to address specific challenges in each industry, such as developing pemafibrate-based sensors for detecting pollutants in air or water.

Potential Commercial Applications and Market

The potential commercial applications of this inventive concept are vast, with opportunities in sustainable agriculture, biofuel production, wastewater treatment, environmental monitoring, and bioremediation. The target markets include industries focused on reducing environmental impact, improving resource efficiency, and developing innovative solutions for a more sustainable future.

Field of Art

Pharmaceutical biotechnology, with expertise in drug metabolism, receptor pharmacology, and industrial applications of bioactive compounds

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degree in biochemistry, pharmacology, or biotechnology, familiar with receptor agonists, drug repurposing, and interdisciplinary applications of pharmaceutical compounds

Obviousness Rationale

A PHOSITA would recognize that pemafibrate's PPARα activity provides a versatile molecular mechanism that could be systematically explored across multiple industrial domains. The PTD demonstrates predictable extensions of the source patent by applying the compound's known receptor modulation properties to solve technical challenges in agriculture, biofuel production, and environmental management. These applications represent logical extrapolations of pemafibrate's fundamental molecular characteristics.

Obvious Combinations & Variations

Source Patent Element
Pemafibrate's established PPARα activity for treating dyslipidemia
PTD Variation
Using pemafibrate to stimulate lipid biosynthesis in microorganisms for biofuel production
Obviousness Reasoning
A PHOSITA would recognize that PPARα receptor modulation could predictably influence lipid metabolism across biological systems, making biofuel applications a straightforward technical extension
Source Patent Element
Pharmaceutical dosing and metabolic interaction strategies from source patent
PTD Variation
Integrating OATP1B inhibitors to modulate pemafibrate's cellular uptake and metabolic interactions
Obviousness Reasoning
Combining receptor agonists with transport protein modulators represents a known technique for optimizing compound performance across different biological contexts
Source Patent Element
Pemafibrate's molecular mechanism targeting metabolic pathways
PTD Variation
Applying pemafibrate to stimulate microbial degradation in bioremediation processes
Obviousness Reasoning
A PHOSITA would understand that receptor agonists capable of modulating metabolic pathways could be predictably applied to enhance microbial metabolic processes
Source Patent Element
Pharmaceutical compound with demonstrated receptor interaction capabilities
PTD Variation
Developing pemafibrate-based environmental sensors for pollutant detection
Obviousness Reasoning
Repurposing bioactive molecules for sensing applications represents a standard approach in biotechnology, particularly when the molecule demonstrates specific receptor interactions
Source Patent Element
Pharmaceutical composition with established safety profile
PTD Variation
Using pemafibrate as a plant growth promoter with toxicity reduction capabilities
Obviousness Reasoning
Extending pharmaceutical compounds into agricultural applications is a predictable innovation when the compound demonstrates metabolic modulation and low toxicity
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857540 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as they represent foreseeable extensions of pemafibrate's established molecular mechanism through systematic exploration of its PPARα activity across diverse technical domains. The disclosed combinations constitute prima facie obviousness under 35 U.S.C. § 103, rendering subsequent claims involving similar technical applications unpatentable.

Original Patent Information

Patent NumberUS 11,857,540
TitlePemafibrate dosing regimens
Assignee(s)KOWA COMPANY, LTD.